Navigation Links
Ansell Healthcare Receives CE Mark for GAMMEX® Powder-Free Gloves With AMT Antimicrobial Technology
Date:10/17/2011

BRUSSELS, October 17, 2011 /PRNewswire/ --

Novel Gloves First to be Classified as Class III Medical Devices

Ansell Healthcare, a global leader in healthcare barrier protection, announced today that it has received the CE Mark for GAMMEX® Powder-Free gloves with AMT Antimicrobial Technology. Through its unique virus and bacteria-killing technology, the novel GAMMEX® Powder-Free with AMT provides protection against some of the most common pathogens and drug-resistant bacteria in the event of a glove breach*. Ansell will commercially launch GAMMEX® Powder-Free gloves with AMT across Europe in the autumn of 2011.

"We look forward to bringing a new level of protection and peace of mind to the surgical staff," said Peter Dobbelsteijn, Senior Vice President EMEA, Ansell Healthcare. "GAMMEX® Powder-Free with AMT has its own immune system to fight back against pathogens that migrate through the breaches that inevitably occur in actual use."

The gloves, made of natural rubber latex, provide the same feel, sensitivity, flexibility and dexterity as conventional gloves when manipulating and handling instruments. The main difference is the active antimicrobial layer which contains chlorhexidine gluconate (CHG). This proprietary technology can provide ongoing antiviral and antibacterial protection against HIV, hepatitis C and infectious bacteria.

"The new GAMMEX® Powder-Free with AMT is a significant technical breakthrough in terms of bringing about a change from passive protection to active protection. These new gloves respond to the demands of healthcare workers in the surgical theatre who face infection risks every day. With AMT Antimicrobial Technology, we can offer healthcare workers an extra level of security. Glove breaches happen during surgery through the use of sharp instruments and with the AMT technology, Ansell provides for a backup plan," said David Lucas, Vice President Science & Technology, Ansell Healthcare.

Receiving the CE Mark is a major milestone in the process of bringing this groundbreaking technology to the European market.

* In clinical and laboratory tests, GAMMEX® Powder-Free with AMT killed at least 99% of invading HIV and HCV (hepatitis C) surrogate pathogens, the two main viruses that concern surgeons. In addition, clinical testing has shown that the gloves kill over 99.7% of eight common infectious bacteria (gram-positive, gram-negative and drug-resistant bacteria) and kill over 99.99% of staphylococcus aureus.

GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology are not proven to protect against blood-borne infections where the skin is broken, cut or punctured.

GAMMEX® Powder-Free Gloves with AMT Antimicrobial Technology contain natural rubber latex, which may cause allergic reactions.

Australia Patent No. 703926 and New Zealand Patent No. 556353. AU and worldwide patents pending.

Ansell, ® and ™ are trademarks owned by Ansell Limited or one of its affiliates.

© 2011 Ansell Limited. All rights reserved.

About Ansell

Ansell is a world leader in providing superior health and safety protection solutions that enhance human well being. With operations in North America, Latin America, EMEA and Asia, Ansell employs more than 10,000 people worldwide and holds leading positions in the natural latex and synthetic polymer glove and condom markets. Ansell operates in four main business

segments: Medical Solutions, Industrial Solutions, New Verticals and Sexual Wellness. Information on Ansell and its products can be found at http://www.ansell.eu

For the press pack and photographs, please click here: http://www.anselleurope.com/medical/index.cfm?page=gammex_pf_amt&lang=EN

 



'/>"/>
SOURCE Ansell Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ansell Limited Acquires Sandel Medical Industries LLC, an Innovator in Surgical Safety Solutions
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. ViroPharma to Present at Three Upcoming Healthcare Conferences
5. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
6. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
7. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
8. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
9. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
10. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
11. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology:
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):